Some researchers believe DMT, a powerful psychedelic that may naturally occur in the brain, could be your soul’s “ferryman.” ...

The Tyson-Paul fight had to be re-scheduled from July 20 to Nov. 15 after Tyson had a medical emergency on a plane during the ...

After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Cantor Fitzgerald analyst Charles Duncan initiated coverage of GH Research (GHRS) with an Overweight rating and no price target GH Research is ...

Jake Paul’s controversial fight with Mike Tyson is back in the spotlight after the YouTuber’s latest on screen blunder. The ...

Research analysts at Cantor Fitzgerald issued their FY2024 EPS estimates for shares of GH Research in a report released on ...

Jake Paul and Mike Tyson took the internet by storm for their face-off in the ring last year. Their anticipated fight ended with Paul winning via unanimous decision.

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks after J&J secured FDA monotherapy approval for its esketamine nasal spray ...

Fintel reports that on February 13, 2025, Cantor Fitzgerald initiated coverage of GH Research (NasdaqGM:GHRS) with a ...

This synthetic intranasal formulation of 5-MeO-DMT benzoate is designed to deliver a durable treatment option to AUD and other psychiatric disorders. The drug, along with relapse prevention ...

Cantor Fitzgerald assumed coverage on shares of GH Research (NASDAQ:GHRS – Free Report) in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. The firm issued an ...

Sarah Napthali lowers her voice over lunch when our conversation veers to the names of the drugs she used: LSD, MDMA, ...